-
Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study
Waterink, L., Masselink, L. A., van der Lee, S. J., Visser, L. N. C., Cleutjens, S., van der Schaar, J., van Harten, A. C., Scheltens, P., Sikkes, S. A. M., van der Flier, W. M. & Zwan, M. D., 1 Dec 2024, In: Alzheimer's Research & Therapy. 16, 1, p. 1 1.Research output: Contribution to journal › Article › Academic › peer-review
-
Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
Wang, S-M., Kang, D. W., Um, Y. H., Kim, S., Lee, C. U., Scheltens, P. & Lim, H. K., 1 Dec 2024, In: Alzheimer's Research and Therapy. 16, 1, 55.Research output: Contribution to journal › Article › Academic › peer-review
-
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer’s disease: a systematic review
Oosthoek, M., Vermunt, L., de Wilde, A., Bongers, B., Antwi-Berko, D., Scheltens, P., van Bokhoven, P., Vijverberg, E. G. B. & Teunissen, C. E., 1 Dec 2024, In: Alzheimer's Research and Therapy. 16, 1, 93.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
